SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008364
Filing Date
2016-03-30
Accepted
2016-03-30 07:04:35
Documents
93
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1561509
2 ex31-1.htm EX-31.1 21031
3 ex31-2.htm EX-31.2 20963
4 ex32-1.htm EX-32.1 8338
5 ex32-2.htm EX-32.2 8951
  Complete submission text file 0001493152-16-008364.txt   5815295

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20151231.xml EX-101.INS 928032
7 XBRL SCHEMA FILE aker-20151231.xsd EX-101.SCH 65412
8 XBRL CALCULATION FILE aker-20151231_cal.xml EX-101.CAL 75893
9 XBRL DEFINITION FILE aker-20151231_def.xml EX-101.DEF 210424
10 XBRL LABEL FILE aker-20151231_lab.xml EX-101.LAB 451522
11 XBRL PRESENTATION FILE aker-20151231_pre.xml EX-101.PRE 340329
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 161536981
SIC: 2835 In Vitro & In Vivo Diagnostic Substances